Monte Rosa Therapeutics (GLUE) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $5.0 million.
- Monte Rosa Therapeutics' Other Non-Current Assets rose 85.57% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 85.57%. This contributed to the annual value of $4.9 million for FY2024, which is 617.9% up from last year.
- According to the latest figures from Q3 2025, Monte Rosa Therapeutics' Other Non-Current Assets is $5.0 million, which was up 85.57% from $5.0 million recorded in Q2 2025.
- In the past 5 years, Monte Rosa Therapeutics' Other Non-Current Assets registered a high of $5.3 million during Q1 2023, and its lowest value of $4.5 million during Q3 2023.
- Over the past 3 years, Monte Rosa Therapeutics' median Other Non-Current Assets value was $4.9 million (recorded in 2024), while the average stood at $4.8 million.
- Examining YoY changes over the last 5 years, Monte Rosa Therapeutics' Other Non-Current Assets showed a top increase of 853.6% in 2024 and a maximum decrease of 791.52% in 2024.
- Over the past 3 years, Monte Rosa Therapeutics' Other Non-Current Assets (Quarter) stood at $4.6 million in 2023, then increased by 6.18% to $4.9 million in 2024, then increased by 1.79% to $5.0 million in 2025.
- Its last three reported values are $5.0 million in Q3 2025, $5.0 million for Q2 2025, and $4.9 million during Q1 2025.